C07K 14/4743
Insulin-like growth factor binding protein
Official title: {Insulin-like growth factor binding protein}
C07K14/4743 (Insulin-like growth factor binding protein) appears on 122 US grants and 125 published applications in this corpus.
Search patents in C07K- Granted patents
- 122
- Published applications
- 125
- Assignees
- 76
- Inventors
- 250
- Latest grant
- 30 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 4 | 0 |
| 1998 | 10 | 0 |
| 1999 | 10 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 1 |
| 2002 | 9 | 6 |
| 2003 | 6 | 13 |
| 2004 | 10 | 3 |
| 2005 | 6 | 8 |
| 2006 | 4 | 8 |
| 2007 | 2 | 4 |
| 2008 | 3 | 5 |
| 2009 | 5 | 6 |
| 2010 | 2 | 7 |
| 2011 | 2 | 3 |
| 2012 | 3 | 4 |
| 2013 | 2 | 2 |
| 2014 | 1 | 5 |
| 2015 | 2 | 3 |
| 2016 | 1 | 3 |
| 2017 | 0 | 4 |
| 2018 | 1 | 2 |
| 2019 | 4 | 6 |
| 2020 | 3 | 6 |
| 2021 | 3 | 3 |
| 2022 | 2 | 4 |
| 2023 | 1 | 5 |
| 2024 | 5 | 6 |
| 2025 | 4 | 4 |
| 2026 | 1 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Production method for organoid30 Jun 2026US 12,668,773 B2Jsr Corporation
- Peptides and combination of peptides for use in immunotherapy against cancers11 Nov 2025US 12,466,878 B2Immatics Biotechnologies GmbH
- Insulin like growth factor binding protein bioactive peptide fragments23 Sep 2025US 12,421,280 B2Northwestern University
- Modulation of mammalian cell lineage by synthetic immodulins9 Sep 2025US 12,410,220 B2
- Identification and medical applications of anti-citrullinated-protein antibodies in rheumatoid arthritis25 Feb 2025US 12,235,268 B2Benaroya Research Institute at Virginia Mason
- Method for preventing or treating cancer by blocking excessive production of phosphorylated igfbp523 Jul 2026US 2026/0209298 A1Industry-University Cooperation Foundation Hanyang University Erica Campus
- Insulin like growth factor binding protein bioactive peptide fragments26 Feb 2026US 2026/0055140 A1Northwestern University
- Peptides and combination of peptides for use in immunotherapy against cancers12 Feb 2026US 2026/0042828 A1Immatics Biotechnologies GmbH
- Therapeutic or preventive agent for myocardial infarction, cardiac fibrosis, or heart failure using htra3 as therapeutic target1 Jan 2026US 2026/0000742 A1Osaka University
- Identification and medical applications of anti-citrullinated-protein antibodies in rheumatoid arthritis22 May 2025US 2025/0164481 A1
Most cited
By later US patents
- Methods for producing heterologous disulfide bond-containing polypeptides in bacterial cells160US 6,083,715 ABoard of Regents, The University of Texas System · 2000
- Expression of fusion polypeptides transported out of the cytoplasm without leader sequences85US 5,914,254 ACeltrix Pharmaceuticals, Inc. · 1999
- Use of binding protein with IGF-I as an anabolic growth promoting agent78US 5,187,151 AGenentech, Inc. · 1993
- Immunoassay of total insulin-like growth factor binding protein-141US 5,747,273 ADiagnostic Systems Laboratories, Inc. · 1998
- Chromosomal expression of non-bacterial genes in bacterial cells40US 5,470,727 ACeltrix Pharmaceuticals, Inc. · 1995